Essential Medical Inc. Announces the Successful Initiation of the U.S. MANTA Vascular Closure Device Trial With the First Patients Enrolled in TAVR and EVAR Cases

MALVERN, Pennsylvania, December 12, 2016 -- (Healthcare Sales & Marketing Network) -- Essential Medical, Inc., a privately held medical device company addressing the rapidly growing $600M large bore vascular closure market, announced today the start of th... Devices, Interventional, Cardiology Essential Medical, MANTA, Vascular Closure, TAVR
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news